Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
about
Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compoundsDesign and optimization of PLGA-based diclofenac loaded nanoparticlesDoxorubicin nanobubble for combining ultrasonography and targeted chemotherapy of rabbit with VX2 liver tumor.Heterogeneous catalysis for sustainable biodiesel production via esterification and transesterification.Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.Evaluation of mucoadhesive PLGA microparticles for nasal immunization.Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challengeLipid and polymeric carrier-mediated nucleic acid delivery.Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives.Synthesis and characterization of PLGA nanoparticles.Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticlesPolymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells.Therapeutic Use of 3β-[N-(N',N'-Dimethylaminoethane) Carbamoyl] Cholesterol-Modified PLGA Nanospheres as Gene Delivery Vehicles for Spinal Cord Injury.Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity.Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.Strategies for DNA vaccine delivery.Non-viral therapeutic approaches to ocular diseases: An overview and future directionsNanobiomaterials: a review of the existing science and technology, and new approaches.Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines.Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles.Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injuryInnovative strategies for co-delivering antigens and CpG oligonucleotides.Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers.Cancer, chitosan nanoparticles and catalytic nucleic acids.Morphological effects of HA on the cell compatibility of electrospun HA/PLGA composite nanofiber scaffolds.Delivery of therapeutic proteins.Development of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy.Nanosponge formation from organocatalytically-synthesized poly(carbonate) copoplymersCentral nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.Marine polysaccharides in pharmaceutical applications: an overviewProgress towards a needle-free hepatitis B vaccine.
P2860
Q27333474-C58815D2-A64C-4298-86E1-4C8AD684D12FQ28477252-4592FBEC-D5A9-4156-9A4B-32DDA050189CQ28539253-CF828D5D-8AB6-4F1F-9165-6F163AFED417Q30375538-FFF7BCD9-7290-44FC-8D85-3DF64E22BB63Q30832913-D18B632F-C0F4-43A6-B519-CF874D36F1D1Q33284334-FCEF439D-90C7-476E-807F-51339E210592Q33749489-86FA0889-37AD-40B4-897C-A6BAAB592131Q33882801-698BECF1-2324-4AD6-BA11-861AED112758Q34081625-710A0202-CE2F-4EB2-A4F5-AE4A5E0EF936Q34155795-71874F06-42F7-47E8-80B7-58204E853024Q34309830-37F155FE-73FA-4308-A1DA-F761A10F8353Q34524402-9D5E4E7E-C222-4A5E-A431-52BFACDF80A6Q34661842-0795EEEF-16D2-46C5-83B1-405E264BD566Q34775944-C30DC5E2-FBE8-4F77-B7E4-1EEB9C8101EAQ35027496-7B9A3CD2-2196-4C0C-8BAB-9E9D0629F338Q35071594-DE31CAF9-93BB-4424-969D-2ABBB0C0DCEBQ35537936-41E164A9-A3C6-4C10-AE3F-6E909B51261BQ35908465-FBD0192C-4493-4BE2-A436-F7BCB151C759Q35992063-400A13AF-90A9-4A87-8631-79F6FBC41E27Q35997275-D951E97C-1DA3-4CE9-9DC2-0727227569CFQ36176908-73111B7E-C62B-4999-B23D-8844CB45A684Q36289194-35E6B639-2732-4724-AE26-2DC89FAE7AABQ36316818-01BBEC73-F6AE-4092-B392-3CE08A9D094AQ36425890-3237FCE1-8BDA-4F13-890B-3C319CB7F41EQ36687177-0E316BB1-8BF8-4AC5-9F1D-C717D1960E62Q36839366-78BB2815-41CB-4321-A5CB-813E91F981BBQ36852020-A7CA00A6-B6D8-42B4-819B-8475DE27BEE4Q36929225-9DCC352E-BFE3-4E74-AF1C-A183D7F44408Q37033697-B2DF68EF-7A90-4A7B-AC91-7B42999C3415Q37093144-27C8B71C-B0A5-40E4-88D9-EBDB549931A2Q37130626-2C676A1D-8A88-465E-839D-ECDAAA151FE2Q37360665-6CB57F3D-8344-4B97-A52A-523588836911Q37363420-09CBD515-0207-4950-BD36-D893E62677EEQ37639870-78423487-13B8-49F3-AFBA-612CF902D202Q37668486-F510482D-0B95-4366-A3F1-C24F81A40989Q37683953-759973EC-5973-496A-B7DC-1C844AAC86DCQ37692022-CF6FB533-9E04-46AB-89A9-5B84586EBF1BQ37702246-D3637258-81F0-4F99-AF1D-DD5C1EFCC06EQ37800376-C942423F-5E18-40D1-AEB1-02EAB6784C87Q37810816-83C0EC7F-E2A8-48DA-80FE-04AAAEB87FB8
P2860
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@en
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@nl
type
label
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@en
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@nl
prefLabel
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@en
Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
@nl
P1433
P1476
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
@en
P2093
M N V Ravi Kumar
P304
P356
10.1016/J.BIOMATERIALS.2003.08.069
P577
2004-05-01T00:00:00Z